Company Data

Zynerba Pharmaceuticals Inc.

Ticker
ZYNE
Current Price
$0.5602 4.77%
Market Cap
$26.4M
Price Target
Refer to Report
Volume
183.9K
52wk Range
$0.5001 - $3.66
Advanced Market Data

Overview

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.